A little slower in part because of travel restrictions and, frankly, the demand in construction and those things and going around the country.
Aug 4, 2022 / receipt, needs a key / Michael Carroll, other | earnings call 2022-08-04 | transcript 3879ba0a-dbc0-47ba-a73c-a1ee04fab7fe | chars 28837-28979 | segment 29
A little slower in part because of travel restrictions and, frankly, the demand in construction and those things and going around the country.
Aug 4, 2021 / receipt, needs a key / Michael Carroll, other | earnings call 2021-08-04 | transcript 5846ae2f-5910-4ece-850d-a2b1366afa4a | chars 28948-29090 | segment 29
Looking ahead to 2021, we expect G&A costs to increase as we resume normal levels of travel and acquisition activity, resulting in projected G&A costs between $36 to $38 million for the year.
Feb 25, 2021 / receipt, needs a key / Jeff, CEO | earnings call 2021-02-25 | transcript faf5edce-c7ce-439e-92c4-6ab95d0af9d2 | chars 12664-12855 | segment 12
General and administrative expense attributable to Janus Living(1) $19 +$1
ir_statement / Sep 15, 2026 / receipt
Healthpeak proceeds from joint ventures, dispositions and/or loan repayments(2) $1,900 +$900
ir_statement / Sep 15, 2026 / receipt
Janus Living cash including net IPO, follow-on proceeds and/or credit facilities $1,600 +$625
ir_statement / Sep 15, 2026 / receipt
Janus Living post-IPO acquisitions(4) $1,600 +$850
ir_statement / Sep 15, 2026 / receipt
Authorized new $500 million share repurchase program
ir_statement / Sep 15, 2026 / receipt
Entered into a new $20 million outpatient medical development agreement to support Northside Hospital’s continued expansion in the Atlanta market
ir_statement / Sep 15, 2026 / receipt
Increases Full Year 2026 Earnings Guidance
ir_statement / Sep 15, 2026 / receipt
$70M of realized cost and operational synergies
ir_statement / Sep 15, 2026 / receipt
~60% of Healthpeak employees now directly support our clients and real estate
ir_statement / Sep 15, 2026 / receipt
40M SF of Healthpeak Outpatient Medical & Lab are now internally property managed
ir_statement / Sep 15, 2026 / receipt
| J. Justin Hutchens | President | - | receipt |
| James B. Connor | director | - | receipt |
| James Hoffmann | director | - | receipt |
| Jeff Tyler | CFO | - | receipt |
| John Thomas | CEO | - | receipt |
| Katherine M. Sandstrom | director | - | receipt |
| Kelvin O. Moses | Chief Financial Officer | receipt | |
| Mark Thine | EVP, Asset Management | - | receipt |
| Peter A. Scott | Executive Vice President and Chief Financial Officer | - | receipt |
| Sara Grootwassink Lewis | director | - | receipt |
| Scott M. Brinker | President and Chief Executive Officer | - | receipt |
| Shawn G. Johnston | Senior Vice President and Chief Accounting Officer | - | receipt |
| Thomas M. Herzog | Chief Executive Officer | - | receipt |
| Thomas M. Klaritch | Executive Vice President and Chief Operating Officer | - | receipt |
| 2025-04-24 | Chief Financial Officer, appointed | sec_8k |
| 2023-03-14 | director, appointed | sec_8k |
| 2022-10-06 | President and Chief Executive Officer, appointed | sec_8k |
| 2019-11-05 | director, appointed | sec_8k |
| 2018-08-02 | director, appointed | sec_8k |
| 2018-02-05 | Executive Chairman, departed | sec_8k |
| 2017-08-30 | Executive Vice President and Chief Operating Officer, appointed | sec_8k |
| 2017-07-11 | Senior Vice President and Chief Accounting Officer, appointed | sec_8k |
| 2017-05-15 | Executive Vice President and Chief Investment Officer, appointed | sec_8k |
| 2017-01-23 | Executive Vice President and Chief Financial Officer, appointed | sec_8k |
| 2017-01-03 | Chief Executive Officer, appointed | sec_8k |
| 2017-01-03 | President, appointed | sec_8k |